ConductScience.org, home

Paper17526729

Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.

Li L and 8 others. Mol Cell Biol, 2007. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Papers, record 17526729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17526729

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.
PubMed
Journal
Mol Cell Biol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li LLianjie
2Zhang LLiang
3Zhang XXiaoping
4Yan QQin
5Minamishima YAYoji Andrew
6Olumi AFAria F
7Mao MMao
8Bartz SSteven
9Kaelin WG JrWilliam G

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Basic Helix-Loop-Helix ProteinsMajor topic
Carcinoma, Renal CellMajor topic
Kidney NeoplasmsMajor topic
MutationMajor topic
Von Hippel-Lindau Tumor Suppressor ProteinMajor topic
Animals
Cell Cycle
Cell Line, Tumor
Cell Proliferation
Down-Regulation
Gene Expression Profiling
Humans
Mice
Mutant Proteins
Risk Factors
Spheroids, Cellular
Endothelial PAS Domain-Containing Protein 1

Source PubMed

Download CSV of topics

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116261165Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions.Oncogene2006https://conductscience.org/library/papers/16261165PubMed
210353251The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.Nature1999https://conductscience.org/library/papers/10353251PubMed
310579999The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.Genes Dev1999https://conductscience.org/library/papers/10579999PubMed
414985465Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.Mol Cancer Res2004https://conductscience.org/library/papers/14985465PubMed
511171994Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11171994PubMed
69238051Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9238051PubMed
711292861Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.Science2001https://conductscience.org/library/papers/11292861PubMed
816585181Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.Cancer Res2006https://conductscience.org/library/papers/16585181PubMed
912209156Molecular basis of the VHL hereditary cancer syndrome.Nat Rev Cancer2002https://conductscience.org/library/papers/12209156PubMed
1016339096Renal-cell carcinoma.N Engl J Med2005https://conductscience.org/library/papers/16339096PubMed
1110587522Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.J Clin Invest1999https://conductscience.org/library/papers/10587522PubMed
1216103922A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.PLoS Genet2005https://conductscience.org/library/papers/16103922PubMed
1314506252The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen.J Biol Chem2003https://conductscience.org/library/papers/14506252PubMed
1411598268A conserved family of prolyl-4-hydroxylases that modify HIF.Science2001https://conductscience.org/library/papers/11598268PubMed
1516098468Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.Cancer Cell2005https://conductscience.org/library/papers/16098468PubMed
1611154273VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.Mol Cell Biol2001https://conductscience.org/library/papers/11154273PubMed
1711292862HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.Science2001https://conductscience.org/library/papers/11292862PubMed
1810205047Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.Science1999https://conductscience.org/library/papers/10205047PubMed
1912124175HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.Cancer Cell2002https://conductscience.org/library/papers/12124175PubMed
2012086861The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.Cancer Cell2002https://conductscience.org/library/papers/12086861PubMed

See all 78 referencesDownload CSV of references

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
40522994PHD3-VHL axis controls HIV-2 infection through oxygen-dependent hydroxylation and degradation of Vpx.PLoS Pathog2025https://conductscience.org/library/papers/40522994PubMed
39592433Loss of SETD2 in wild-type VHL clear cell renal cell carcinoma sensitizes cells to STF-62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis.Mol Oncol2025https://conductscience.org/library/papers/39592433PubMed
39281922Molecular Dynamics Reveals Altered Interactions between Belzutifan and HIF-2 with Natural Variant G323E or Proximal Phosphorylation at T324.ACS Omega2024https://conductscience.org/library/papers/39281922PubMed
37139155Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells.Front Oncol2023https://conductscience.org/library/papers/37139155PubMed
36358771The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?Cancers (Basel)2022https://conductscience.org/library/papers/36358771PubMed
36106637Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer.J Clin Invest2022https://conductscience.org/library/papers/36106637PubMed
36040300Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata.Elife2022https://conductscience.org/library/papers/36040300PubMed
35740352p53 and Its Isoforms in Renal Cell Carcinoma-Do They Matter?Biomedicines2022https://conductscience.org/library/papers/35740352PubMed
35205407The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.Genes (Basel)2022https://conductscience.org/library/papers/35205407PubMed
35159281Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines.Cells2022https://conductscience.org/library/papers/35159281PubMed
35158796The Obscure Potential of AHNAK2.Cancers (Basel)2022https://conductscience.org/library/papers/35158796PubMed
34860252pVHL-mediated SMAD3 degradation suppresses TGF-β signaling.J Cell Biol2022https://conductscience.org/library/papers/34860252PubMed
33945366MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma.Expert Opin Investig Drugs2021https://conductscience.org/library/papers/33945366PubMed
33020645Targeting the HIF2-VEGF axis in renal cell carcinoma.Nat Med2020https://conductscience.org/library/papers/33020645PubMed
32725274Interaction with p53 explains a pro-proliferative function for VHL in cancer.J Mol Med (Berl)2020https://conductscience.org/library/papers/32725274PubMed
31810986TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss.Cancer Discov2020https://conductscience.org/library/papers/31810986PubMed
31444342Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome.Nat Commun2019https://conductscience.org/library/papers/31444342PubMed
30105105Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation.Case Rep Endocrinol2018https://conductscience.org/library/papers/30105105PubMed
30104738Endogenous HIF2A reporter systems for high-throughput functional screening.Sci Rep2018https://conductscience.org/library/papers/30104738PubMed
30026228VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.Science2018https://conductscience.org/library/papers/30026228PubMed

See all 70 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPAS12034PubTator's text mininghttps://conductscience.org/library/genes/2034NCBI Gene
VHL7428PubTator's text mininghttps://conductscience.org/library/genes/7428NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17526729

GET https://conductscience.org/api/papers/v1/17526729/references?page=2